Clinical trial
Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic…
NCT00435448 · Threshold Pharmaceuticals, Industry · Terminated
Key facts
| NCT number | NCT00435448 |
|---|---|
| Title | Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia |
| Official title | A Randomized Phase 3, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia |
| Lead sponsor | Threshold Pharmaceuticals, Industry |
| Collaborators | PRA Health Sciences Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Benign Prostatic Hyperplasia, Enlarged Prostate |
| Intervention type | Drug |
| Interventions | Lonidamine |
| Enrollment | 480 |
| Start date | Jun 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Feb 15, 2007 |
| Last update posted | Apr 29, 2009 |
| Countries | Germany, Hungary, Italy, Poland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: